Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

DSpace Repository

Show simple item record

dc.contributor.author Klein, Reinhild
dc.contributor.author Schwab, Matthias
dc.date.accessioned 2014-02-04T10:25:52Z
dc.date.available 2014-02-04T10:25:52Z
dc.date.issued 2013
dc.identifier.issn 1932-6203
dc.identifier.uri http://hdl.handle.net/10900/40554
dc.language.iso en en
dc.publisher Public Library Science de_DE
dc.relation.uri http://dx.doi.org/10.1371/journal.pone.0078856 de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 500 de_DE
dc.title Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments de_DE
dc.type Artikel de_DE
utue.quellen.id 20140116051827_00199 de_DE
utue.personen.roh Latus, Joerg
utue.personen.roh Klein, Reinhild
utue.personen.roh Koetter, Ina
utue.personen.roh Schwab, Matthias
utue.personen.roh Fritz, Peter
utue.personen.roh Kimmel, Martin
utue.personen.roh Alscher, M. Dominik
utue.personen.roh Braun, Niko
dcterms.isPartOf.ZSTitelID Plos One de_DE
dcterms.isPartOf.ZS-Issue Article e78856 de_DE
dcterms.isPartOf.ZS-Volume 8 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record